MEDTRONIC PLC (2M6.DE) Stock Fundamental Analysis
Europe - FRA:2M6 - IE00BTN1Y115 - Common Stock
78.81 EUR
-0.46 (-0.58%)
2M6 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. 2M6 has an excellent profitability rating, but there are some minor concerns on its financial health. 2M6 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 2M6 was profitable.
2M6 had a positive operating cash flow in the past year.
2M6 had positive earnings in each of the past 5 years.
Each year in the past 5 years 2M6 had a positive operating cash flow.
1.2 Ratios
2M6 has a better Return On Assets (5.12%) than 66.67% of its industry peers.
The Return On Equity of 2M6 (9.73%) is better than 65.08% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.74%, 2M6 is in the better half of the industry, outperforming 60.32% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 2M6 is below the industry average of 9.00%.
The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| ROIC | 6.74% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1.3 Margins
2M6 has a better Profit Margin (13.63%) than 82.54% of its industry peers.
In the last couple of years the Profit Margin of 2M6 has declined.
2M6 has a better Operating Margin (19.57%) than 87.30% of its industry peers.
In the last couple of years the Operating Margin of 2M6 has remained more or less at the same level.
2M6 has a Gross Margin of 65.38%. This is in the better half of the industry: 2M6 outperforms 69.84% of its industry peers.
In the last couple of years the Gross Margin of 2M6 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.57% | ||
| PM (TTM) | 13.63% | ||
| GM | 65.38% |
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2. Health
2.1 Basic Checks
2M6 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
2M6 has less shares outstanding than it did 1 year ago.
2M6 has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 2M6 has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.89 indicates that 2M6 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.89, 2M6 perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
2M6 has a debt to FCF ratio of 5.39. This is a neutral value as 2M6 would need 5.39 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.39, 2M6 is in line with its industry, outperforming 53.97% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that 2M6 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.55, 2M6 is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.39 | ||
| Altman-Z | 2.89 |
ROIC/WACC1
WACC6.75%
2.3 Liquidity
2M6 has a Current Ratio of 2.01. This indicates that 2M6 is financially healthy and has no problem in meeting its short term obligations.
2M6 has a Current ratio (2.01) which is in line with its industry peers.
2M6 has a Quick Ratio of 1.50. This is a normal value and indicates that 2M6 is financially healthy and should not expect problems in meeting its short term obligations.
2M6 has a better Quick ratio (1.50) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.53% over the past year.
Measured over the past 5 years, 2M6 shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
Looking at the last year, 2M6 shows a small growth in Revenue. The Revenue has grown by 4.98% in the last year.
2M6 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.01% yearly.
EPS 1Y (TTM)5.53%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%2.44%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.68%
3.2 Future
2M6 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
EPS Next 5Y6.47%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.84%
Revenue Next 5Y5.37%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.45, which indicates a correct valuation of 2M6.
2M6's Price/Earnings ratio is rather cheap when compared to the industry. 2M6 is cheaper than 92.06% of the companies in the same industry.
2M6 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.84, which indicates a correct valuation of 2M6.
Based on the Price/Forward Earnings ratio, 2M6 is valued a bit cheaper than 77.78% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.55. 2M6 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.45 | ||
| Fwd PE | 14.84 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 2M6 is valued a bit cheaper than 68.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 2M6 is valued a bit cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.02 | ||
| EV/EBITDA | 13.53 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2M6 does not grow enough to justify the current Price/Earnings ratio.
2M6 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.96
PEG (5Y)4.47
EPS Next 2Y5.62%
EPS Next 3Y6.2%
5. Dividend
5.1 Amount
2M6 has a Yearly Dividend Yield of 3.12%. Purely for dividend investing, there may be better candidates out there.
2M6's Dividend Yield is rather good when compared to the industry average which is at 2.13. 2M6 pays more dividend than 92.06% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, 2M6 pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.12% |
5.2 History
The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
77.27% of the earnings are spent on dividend by 2M6. This is not a sustainable payout ratio.
2M6's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP77.27%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
FRA:2M6 (10/31/2025, 7:00:00 PM)
78.81
-0.46 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.1%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap101.09B
Revenue(TTM)34.20B
Net Income(TTM)4.66B
Analysts73.33
Price Target88.96 (12.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.12% |
Yearly Dividend2.4
Dividend Growth(5Y)5.1%
DP77.27%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.54%
Min EPS beat(2)1.49%
Max EPS beat(2)1.59%
EPS beat(4)3
Avg EPS beat(4)1.05%
Min EPS beat(4)-0.08%
Max EPS beat(4)1.59%
EPS beat(8)6
Avg EPS beat(8)1.56%
EPS beat(12)9
Avg EPS beat(12)1.82%
EPS beat(16)10
Avg EPS beat(16)1.17%
Revenue beat(2)2
Avg Revenue beat(2)0.54%
Min Revenue beat(2)0.17%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)9
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)-0.26%
PT rev (1m)3.51%
PT rev (3m)4.89%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-0.71%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)1.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.45 | ||
| Fwd PE | 14.84 | ||
| P/S | 3.42 | ||
| P/FCF | 22.02 | ||
| P/OCF | 16.34 | ||
| P/B | 2.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.53 |
EPS(TTM)4.79
EY6.08%
EPS(NY)5.31
Fwd EY6.74%
FCF(TTM)3.58
FCFY4.54%
OCF(TTM)4.82
OCFY6.12%
SpS23.08
BVpS32.32
TBVpS-3.6
PEG (NY)4.96
PEG (5Y)4.47
Graham Number59.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| ROCE | 8.43% | ||
| ROIC | 6.74% | ||
| ROICexc | 7.5% | ||
| ROICexgc | 29.59% | ||
| OM | 19.57% | ||
| PM (TTM) | 13.63% | ||
| GM | 65.38% | ||
| FCFM | 15.51% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.39 | ||
| Debt/EBITDA | 2.72 | ||
| Cap/Depr | 62.54% | ||
| Cap/Sales | 5.39% | ||
| Interest Coverage | 9.24 | ||
| Cash Conversion | 74.13% | ||
| Profit Quality | 113.8% | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 2.89 |
F-Score7
WACC6.75%
ROIC/WACC1
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)5.53%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%2.44%
EPS Next Y3.31%
EPS Next 2Y5.62%
EPS Next 3Y6.2%
EPS Next 5Y6.47%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.68%
Revenue Next Year7.02%
Revenue Next 2Y6.24%
Revenue Next 3Y5.84%
Revenue Next 5Y5.37%
EBIT growth 1Y8.97%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year19.44%
EBIT Next 3Y10.76%
EBIT Next 5Y9.23%
FCF growth 1Y19.33%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y22.55%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%
MEDTRONIC PLC / 2M6.DE FAQ
What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.
What is the valuation status of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.
How profitable is MEDTRONIC PLC (2M6.DE) stock?
MEDTRONIC PLC (2M6.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MEDTRONIC PLC (2M6.DE) stock?
The Price/Earnings (PE) ratio for MEDTRONIC PLC (2M6.DE) is 16.45 and the Price/Book (PB) ratio is 2.44.
How financially healthy is MEDTRONIC PLC?
The financial health rating of MEDTRONIC PLC (2M6.DE) is 5 / 10.